Phibro Animal Health Corp. (PAHC)
37.72
+1.11
(+3.03%)
USD |
NASDAQ |
Oct 07, 16:00
37.74
+0.02
(+0.05%)
After-Hours: 20:00
Phibro Animal Health Gross Profit Margin (Quarterly) : 33.68% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.68% |
| March 31, 2026 | 32.56% |
| December 31, 2025 | 35.39% |
| September 30, 2025 | 32.80% |
| June 30, 2025 | 28.49% |
| March 31, 2025 | 31.93% |
| December 31, 2024 | 31.92% |
| September 30, 2024 | 32.50% |
| June 30, 2024 | 31.77% |
| March 31, 2024 | 30.25% |
| December 31, 2023 | 31.42% |
| September 30, 2023 | 29.20% |
| June 30, 2023 | 30.09% |
| March 31, 2023 | 30.90% |
| December 31, 2022 | 31.78% |
| September 30, 2022 | 29.71% |
| June 30, 2022 | 30.99% |
| March 31, 2022 | 29.99% |
| December 31, 2021 | 30.41% |
| September 30, 2021 | 30.33% |
| June 30, 2021 | 31.96% |
| March 31, 2021 | 32.85% |
| December 31, 2020 | 33.18% |
| September 30, 2020 | 32.85% |
| June 30, 2020 | 32.60% |
| Date | Value |
|---|---|
| March 31, 2020 | 33.01% |
| December 31, 2019 | 32.32% |
| September 30, 2019 | 30.56% |
| June 30, 2019 | 32.03% |
| March 31, 2019 | 31.53% |
| December 31, 2018 | 31.46% |
| September 30, 2018 | 32.34% |
| June 30, 2018 | 31.09% |
| March 31, 2018 | 32.69% |
| December 31, 2017 | 33.45% |
| September 30, 2017 | 33.00% |
| June 30, 2017 | 32.42% |
| March 31, 2017 | 32.33% |
| December 31, 2016 | 33.35% |
| September 30, 2016 | 32.45% |
| June 30, 2016 | 31.50% |
| March 31, 2016 | 31.88% |
| December 31, 2015 | 31.89% |
| September 30, 2015 | 31.48% |
| June 30, 2015 | 32.22% |
| March 31, 2015 | 30.87% |
| December 31, 2014 | 29.16% |
| September 30, 2014 | 31.61% |
| June 30, 2014 | 28.91% |
| March 31, 2014 | 27.54% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Zoetis, Inc. | 71.47% |
| ANI Pharmaceuticals, Inc. | 54.97% |
| Corcept Therapeutics, Inc. | 98.41% |
| Veru, Inc. | -- |
| Johnson & Johnson | 68.73% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 29.73% |
| Return on Assets | 7.02% |
| Return on Invested Capital | 8.95% |
| Profit Margin (Quarterly) | 5.47% |
| Operating Margin (Quarterly) | 12.75% |
| Return on Net Operating Assets | 8.16% |